maternal in utero diethylstilbestrol increases hypospadias in offspring

1
Reactions 896 - 6 Apr 2002 Maternal in utero diethylstilbestrol increases hypospadias in offspring Women who were exposed to diethylstilbestrol in utero are marginally, but significantly, more likely to produce sons with hypospadias, according to researchers from The Netherlands. 1 In their study, 16 284 women, who had been diagnosed with fertility disorders, returned a questionnaire designed to identify offspring with hypospadias. Cumulatively, these women reported giving birth to 8934 sons. In utero exposure to diethylstilbestrol was reported in the mothers of 205 boys, 4 of whom had hypospadias. In contrast, only 8 of the remaining 8729 boys had hypospadias, giving a prevalence ratio of hypospadias following maternal in utero exposure to diethylstilbestrol of 21.3 (95% CI 6.5–70.1). The researchers note that the cases of hypospadias in boys with mothers exposed to diethylstilbestrol in utero were more severe than for the other 8 cases, and that hydrocephalus was also present in one of the boys. The risk of hypospadias was unaffected by potential confounding factors, including maternal age at birth and fertility treatment. The researchers point out that their conclusions are based on a small number of cases, and that the absolute risk of hypospadias associated with maternal in utero exposure to diethylstilbestrol is low. They acknowledge the limitations inherent in questionnaire-based retrospective studies, and advise that their findings need confirmation with further epidemiological research. Transgenerational factors not considered In an accompanying commentary, Sonia Hern´ andez- D ´ ıaz, from the Boston University School of Public Health in the US, says that potential transgenerational confounding factors affecting both prenatal maternal exposure to diethylstilbestrol and the risk of hypospadias in the index child were not considered in the study. 2 She comments that there is evidence that hypospadias are more common in sons born to subfertile woman and points out that ‘results from a selected cohort of subfertile women might not be generalisable to all diethylstilbestrol-exposed women’. She does, however, say that the findings are ‘intriguing’, and that further research on exposure to diethylstilbestrol may provide insight into current concerns regarding exposure to weaker estrogens. 1. Klip H, et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 359: 1102-1107, 30 Mar 2002. 2. Hern´ andez-D ´ ıaz S. Iatrogenic legacy from diethylstilbestrol exposure. Lancet 359: 1081-1082, 30 Mar 2002. 800888238 1 Reactions 6 Apr 2002 No. 896 0114-9954/10/0896-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: vudan

Post on 19-Mar-2017

214 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Maternal in utero diethylstilbestrol increases hypospadias in offspring

Reactions 896 - 6 Apr 2002

Maternal in utero diethylstilbestrolincreases hypospadias in offspring

Women who were exposed to diethylstilbestrol inutero are marginally, but significantly, more likely toproduce sons with hypospadias, according toresearchers from The Netherlands.1

In their study, 16 284 women, who had beendiagnosed with fertility disorders, returned aquestionnaire designed to identify offspring withhypospadias. Cumulatively, these women reportedgiving birth to 8934 sons. In utero exposure todiethylstilbestrol was reported in the mothers of 205boys, 4 of whom had hypospadias. In contrast, only 8 ofthe remaining 8729 boys had hypospadias, giving aprevalence ratio of hypospadias following maternal inutero exposure to diethylstilbestrol of 21.3 (95% CI6.5–70.1).

The researchers note that the cases of hypospadias inboys with mothers exposed to diethylstilbestrol in uterowere more severe than for the other 8 cases, and thathydrocephalus was also present in one of the boys. Therisk of hypospadias was unaffected by potentialconfounding factors, including maternal age at birth andfertility treatment.

The researchers point out that their conclusions arebased on a small number of cases, and that the absoluterisk of hypospadias associated with maternal in uteroexposure to diethylstilbestrol is low. They acknowledgethe limitations inherent in questionnaire-basedretrospective studies, and advise that their findings needconfirmation with further epidemiological research.

Transgenerational factors not consideredIn an accompanying commentary, Sonia Hernandez-

Dıaz, from the Boston University School of PublicHealth in the US, says that potential transgenerationalconfounding factors affecting both prenatal maternalexposure to diethylstilbestrol and the risk ofhypospadias in the index child were not considered inthe study.2 She comments that there is evidence thathypospadias are more common in sons born tosubfertile woman and points out that ‘results from aselected cohort of subfertile women might not begeneralisable to all diethylstilbestrol-exposed women’.She does, however, say that the findings are ‘intriguing’,and that further research on exposure todiethylstilbestrol may provide insight into currentconcerns regarding exposure to weaker estrogens.1. Klip H, et al. Hypospadias in sons of women exposed to diethylstilbestrol in

utero: a cohort study. Lancet 359: 1102-1107, 30 Mar 2002.2. Hernandez-Dıaz S. Iatrogenic legacy from diethylstilbestrol exposure. Lancet

359: 1081-1082, 30 Mar 2002.800888238

1

Reactions 6 Apr 2002 No. 8960114-9954/10/0896-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved